• Alnylam Pharmaceuticals average ebit margin for 2024 was -5.27%, a 87.74% decline from 2023.
• Alnylam Pharmaceuticals average ebit margin for 2023 was -42.98%, a 45.45% decline from 2022.
• Alnylam Pharmaceuticals average ebit margin for 2022 was -78.79%, a 26.3% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues